Matches in Wikidata for { <http://www.wikidata.org/entity/Q66396895> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66396895 description "clinical trial" @default.
- Q66396895 description "ensayu clínicu" @default.
- Q66396895 description "klinisch onderzoek" @default.
- Q66396895 description "клінічне випробування" @default.
- Q66396895 name "Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia" @default.
- Q66396895 name "Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia" @default.
- Q66396895 type Item @default.
- Q66396895 label "Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia" @default.
- Q66396895 label "Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia" @default.
- Q66396895 prefLabel "Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia" @default.
- Q66396895 prefLabel "Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia" @default.
- Q66396895 P1050 Q66396895-1E691EB1-5913-443B-A500-262D9FF455C6 @default.
- Q66396895 P1050 Q66396895-3D946EF3-F4B7-4C85-9D51-56BB6F0CAA3B @default.
- Q66396895 P1050 Q66396895-405935AE-F2D6-456A-969B-30247FDAE00B @default.
- Q66396895 P1132 Q66396895-E9292DBE-B647-406D-AC2E-B1DDF4F0FD3F @default.
- Q66396895 P1476 Q66396895-9B75CF72-B3FA-4A2B-B07F-3414772ED053 @default.
- Q66396895 P17 Q66396895-B001275B-AEBD-4973-8DAF-6019E3680332 @default.
- Q66396895 P1813 Q66396895-4D35373C-B030-4F0D-8B7C-37502ABE436F @default.
- Q66396895 P2899 Q66396895-C16EBB93-A634-4E2F-A64D-88748B8AE3BF @default.
- Q66396895 P3098 Q66396895-5733CA09-D456-45AA-9107-881DB2BA2838 @default.
- Q66396895 P31 Q66396895-DE3B0FD0-C1A9-4555-AA94-DCD8B1F525A2 @default.
- Q66396895 P4135 Q66396895-46A4471E-81B0-444A-BA9C-433E57AF1EDF @default.
- Q66396895 P580 Q66396895-186AC4F1-1D48-4FF0-AB40-43913BA43FB3 @default.
- Q66396895 P582 Q66396895-7FECFAA2-EAEC-4046-B5E0-5F31E7CB3310 @default.
- Q66396895 P8363 Q66396895-2DEE827A-1B28-4267-9C02-3BE3AE709429 @default.
- Q66396895 P1050 Q131742 @default.
- Q66396895 P1050 Q154869 @default.
- Q66396895 P1050 Q157661 @default.
- Q66396895 P1132 "+66" @default.
- Q66396895 P1476 "Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Colombia (outCome)" @default.
- Q66396895 P17 Q739 @default.
- Q66396895 P1813 "outCome" @default.
- Q66396895 P2899 "+18" @default.
- Q66396895 P3098 "NCT02851069" @default.
- Q66396895 P31 Q30612 @default.
- Q66396895 P4135 "+99" @default.
- Q66396895 P580 "2017-02-23T00:00:00Z" @default.
- Q66396895 P582 "2018-08-30T00:00:00Z" @default.
- Q66396895 P8363 Q818574 @default.